Katsu Takenaka Selected Research

Mineralocorticoid Receptors (Mineralocorticoid Receptor)

7/2008

Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katsu Takenaka Research Topics

Disease

2	Hypertension (High Blood Pressure) 07/2008 - 01/2008
2	Orthostatic Intolerance 06/2007 - 03/2002
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 11/2020
1	Muscular Diseases (Myopathy) 11/2020
1	Hematologic Diseases (Blood Diseases) 10/2020
1	Coronary Occlusion 01/2019
1	Muscular Dystrophies (Muscular Dystrophy) 05/2016
1	Heart Failure 05/2015
1	Pulmonary Hypertension 05/2015
1	Bland White Garland Syndrome 12/2010
1	Left Ventricular Dysfunction 07/2008
1	Atherosclerosis 01/2008
1	Renal Insufficiency (Renal Failure) 05/2006
1	Cholesterol Embolism 05/2006
1	Ischemia 05/2006
1	Atherosclerotic Plaque (Atheroma) 05/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2005
1	Essential Hypertension 09/2004
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2004

Drug/Important Bio-Agent (IBA)

1	DystrophinIBA 11/2020
1	IronIBA 01/2019
1	Cystatin CIBA 05/2016
1	Inulin FDA Link 05/2016
1	MonocrotalineIBA 05/2015
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 07/2008
1	imidaprilIBA 01/2008
1	Enalapril FDA LinkGeneric 01/2008
1	Losartan (Cozaar)FDA LinkGeneric 01/2008
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2008
1	Angiotensin Receptor AntagonistsIBA 01/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2006
1	CholesterolIBA 05/2006
1	SteroidsIBA 05/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2005
1	Amlodipine (Norvasc)FDA LinkGeneric 09/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2004
1	Dipyridamole (Persantine)FDA LinkGeneric 02/2004
1	Indicators and Reagents (Reagents)IBA 02/2004

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 10/2020
1	Conservative Treatment 12/2010
1	Lower Body Negative Pressure 06/2007
1	Bed Rest (Bedrest) 03/2002